Former FDA chiefs criticize Trump-era cuts, urging rebuilding of public trust in the agency after significant staff losses.
The U.S. tightens visa rules for international researchers and students, with new fees and university investigations sparking concerns over talent retention.
Proposed 2030 U.S. census changes may artificially inflate mortality and morbidity rates by reducing the counted population.
Proposed U.S. Census changes may seriously threaten public health by impacting health research and federal programs.
The U.S. investigates nine top universities—including Harvard and Stanford—for suspected J-1 visa fraud in a probe targeting international biomedical researcher
Energy drinks pose threat to young people due to excessive caffeine consumption, leading to acute illness and death.
Health spending is becoming a key economic driver in the Middle East, as Dr. Olfat Berro from Roche argues that healthy populations…
Deep brain stimulation successfully treats a boy's rare brain disorder, offering hope for similar cases.
Guardant Health patent verdict orders the company to pay $245 million for infringing TwinStrand’s DNA sequencing patents, highlighting risks to industry.
President Trump appoints physician Heidi Overton as the new FDA commissioner to oversee drug approvals and health regulations.